APLS - Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years | Benzinga
Apellis Pharmaceuticals (NASDAQ:APLS) has outperformed the market over the past 5 years by 23.37% on an annualized basis producing an average annual return of 36.05%. Currently, Apellis Pharmaceuticals has a market capitalization of $8.01 billion.
Buying $100 In APLS: If ...